BrightSpring Health Services, Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 4 fiscal years, taken from the XBRL data BrightSpring Health Services, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2022
FY2024
FY2024
FY2025
Revenue
7,721
7,691
10,072
12,911
Gross profit
1,354
1,139
1,266
1,518
Selling, general and administrative
1,126
1,081
1,158
1,223
Operating income
188
58.1
108
295
Interest expense
234
272
191
157
Pre-tax income
-45.8
-214
-95.3
138
Income tax
33.1
-31.5
-26.4
33.1
Income from continuing operations
-180
-66.5
106
Net income to minority interests
-0.31
-2.23
-2.46
-1.55
Net income
-53.9
-155
-18.1
191
EBITDA
392
260
312
460
EPS, basic
-0.46
-1.31
-0.09
0.94
EPS, diluted
-0.46
-1.31
-0.09
0.87
Shares, basic (weighted)
118
118
193
203
Shares, diluted (weighted)
118
118
193
220
Balance sheet
FY2022
FY2024
FY2024
FY2025
Cash and equivalents
13.1
61
88.4
Receivables
882
903
990
Inventory
403
637
815
Other current assets
159
161
119
Total current assets
1,457
1,893
2,894
Property, plant and equipment
246
181
205
Lease right-of-use assets
267
161
172
Goodwill
2,576
2,301
2,364
2,546
Intangible assets
881
595
558
Other non-current assets
72.8
39.1
39.7
Total assets
5,533
5,926
6,413
Accounts payable
642
924
1,218
Accrued liabilities
492
296
333
Deferred revenue
30.8
10.2
9.04
Short-term debt
32.3
48.7
52.3
Total current liabilities
1,248
1,428
1,849
Long-term debt
3,332
2,562
2,455
Lease liabilities
202
129
135
Other non-current liabilities
5.34
6.59
1.61
Total liabilities
4,920
4,275
4,527
Total debt
3,364
2,611
2,508
Paid-in capital
771
1,867
1,954
Retained earnings
-200
-222
-74.6
Other comprehensive income
12.5
1.42
-6.69
Shareholders' equity
585
1,648
1,875
Minority interests
0.67
0
0.07
Total equity
755
585
1,648
1,875
Total liabilities and equity
5,533
5,926
6,413
Shares outstanding
118
174
192
Cash flow statement
FY2022
FY2024
FY2024
FY2025
Net income
-54.2
-157
-20.5
189
Depreciation and amortization
204
202
204
164
Stock-based compensation
3.55
3.92
69.2
70.1
Deferred income tax
-28
-48.3
-29.7
5.55
Change in receivables
-150
-127
-179
-131
Change in inventory
-132
28.7
-237
-178
Cash from operations
-4.65
211
23.8
490
Capital expenditures
-70.1
-73.5
-80.9
-95.5
Acquisitions
-42.5
-63.1
-59.8
-205
Cash from investing
45.4
-134
-140
-305
Debt issued
2,566
Debt repaid
-40.7
-30.4
-3,396
-50.3
Stock issued
0.2
0.6
1.5
25.3
Share buybacks
-0.65
-0.65
-43.2
Cash from financing
-73.8
-76.9
165
-158
Net change in cash
-33.1
-0.56
48.2
27.2
Free cash flow
-74.8
137
-57.1
395
Interest paid
213
304
211
184
Income taxes paid
28.9
37.5
25
27
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $184.31 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
12.4%
Gross profit / revenue.
Operating margin
3.1%
Operating income / revenue.
EBITDA margin
4.2%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
2.1%
Pre-tax income / revenue.
Net margin
2.5%
Net income / revenue.
FCF margin
2.8%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
3.5%
Cash from operations / revenue.
Effective tax rate
16.1%
Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)
17.9%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
6.1%
Net income / average total assets.
Return on invested capital (ROIC)
10.2%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue
9.3%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
0.4%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
0.7%
Capital expenditures / revenue.
D&A / revenue
1.1%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
28.2%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
18.7%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y
19.8%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
3.9%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income growth, 1y
173.5%
Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y
16.3%
Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y
47.1%
EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y
5.5%
Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y
1,962.0%
Operating cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y
13.8%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
8.2%
Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y
13.9%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
23.1%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.59x
Current assets / current liabilities.
Quick ratio
1.09x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.35x
(Cash + short-term investments) / current liabilities.
Debt / equity
1.07x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
36.6%
Total debt / total assets.
Liabilities / assets
65.6%
Total liabilities / total assets.
Net debt
$1.64B
Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA
2.70x
Net debt / EBITDA (twelve months), when EBITDA is positive.
Free cash flow / net income, when net income is positive.
Capex / operating cash flow
20.5%
Capital expenditures / cash from operations, when that is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
$1.66
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$65.24
Revenue / diluted weighted shares.
FCF per share
$1.83
Free cash flow / diluted weighted shares.
Operating cash flow per share
$2.30
Cash from operations / diluted weighted shares.
Book value per share
$10.37
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/E
99.6x
Market cap / net income. Only when net income is positive.
P/S
2.54x
Market cap / revenue.
P/B
17.8x
Market cap / shareholders' equity. Only when equity is positive.
P/FCF
90.6x
Market cap / free cash flow. Only when free cash flow is positive.
P/OCF
72.0x
Market cap / cash from operations, when positive.
EV/Sales
2.65x
Enterprise value / revenue.
EV/EBIT
85.1x
Enterprise value / operating income, when both are positive.
EV/EBITDA
62.6x
Enterprise value / EBITDA, when both are positive.
EV/FCF
94.7x
Enterprise value / free cash flow, when both are positive.
FCF yield
1.1%
Free cash flow / market cap.
Earnings yield
1.0%
Net income / market cap (the inverse of P/E).
What was BrightSpring Health Services, Inc.'s revenue in fiscal 2025?
BrightSpring Health Services, Inc. reported revenue of $12.91B for fiscal 2025, 28.2% higher than the year before.
Was BrightSpring Health Services, Inc. profitable in fiscal 2025?
Yes. Net income was $190.7M, a net margin of 1.5%.
How much free cash flow did BrightSpring Health Services, Inc. generate in fiscal 2025?
Cash from operations of $490.2M minus capital expenditures of $95.5M left free cash flow of $394.7M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.